Yes, my read is they're going to see how things play out with the 4 trials in progress first and then they will consider expanding indications (but focus on OD's) If they data is good, funding more indications will not be an issue at all.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.17 |
Change
-0.220(1.43%) |
Mkt cap ! $1.887B | |||
| Open | High | Low | Value | Volume |
| $15.45 | $15.45 | $15.03 | $6.517M | 428.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7052 | $15.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 199 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |